Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin.
about
Leukotrienes and aspirin induced asthmaOverexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthmaTh2 cytokines and asthma. Interleukin-9 as a therapeutic target for asthmaRelease of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patientsAspirin-sensitive versus non-aspirin-sensitive nasal polyp patients: analysis of leukotrienes/Fas and Fas-ligand expressionDecreased apoptosis and distinct profile of infiltrating cells in the nasal polyps of patients with aspirin hypersensitivityAsthma, nasal polyposis and ulcerative colitis: a new perspectiveThe effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactionsAspirin intolerance and nasal polyposisExpression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthmaIncrease in urinary leukotriene B4 glucuronide concentration in patients with aspirin-intolerant asthma after intravenous aspirin challengeA new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugsThe measurement of leukotrienes in human fluids.The role of leukotrienes and antileukotriene agents in the pathogenesis and treatment of allergic rhinitis.Leukotrienes in rhinitis.An update on the diagnosis and treatment of sinusitis and nasal polyposis.Use of oral montelukast in the treatment of asthma.Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.Enhanced expression of cyclo-oxygenase isoenzyme 2 (COX-2) in asthmatic airways and its cellular distribution in aspirin-sensitive asthma.Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.Mechanisms of vasomotor rhinitis.Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.Ketorolac-induced bronchospasm in an aspirin-intolerant patientEffect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects.Effect of the 5-lipoxygenase inhibitor ZD2138 on aspirin-induced asthma.Mechanism of aspirin sensitivity.Mechanisms and mediators of nasal symptoms in non-allergic rhinitis.A broad-spectrum lipidomics screen of antiinflammatory drug combinations in human blood.The role of leukotrienes in allergic rhinitis: a review.Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?5-Lipoxygenase metabolic contributions to NSAID-induced organ toxicity.Aspirin-intolerant asthma: a comprehensive review of biomarkers and pathophysiology.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Topical nasal lysine aspirin in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis with nasal polyposis.Mast cells in asthma--state of the art.Salbutamol sulfate absorption across Calu-3 bronchial epithelia cell monolayer is inhibited in the presence of common anionic NSAIDs.Asthma mechanisms, determinants of severity and treatment: the role of nedocromil sodium. Report of a workshop held in Whistler, British Columbia, Canada, 18-19 May 1995.Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study.Cysteinyl leukotrienes in asthma: current state of therapeutic evaluation.Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients.
P2860
Q24563001-0161FA16-9EDC-4193-8946-2829B0C47C88Q24564777-1AF07FEF-E2F2-49F5-A147-3F624BB1E220Q24791881-CBE054B5-045B-4578-9998-3A1E3B8D51E8Q28190812-B962D468-FA9D-4B9A-9A4B-FDA2266BCD12Q28192447-6EB0E4E8-B9E0-461A-B8B5-15CC588F308DQ28193060-DC962524-3E29-4DE4-A5E1-5088C7CDB781Q28193641-1862E336-5E28-4326-AC40-78419A1EAEB7Q28193909-E9540F28-D08C-45C4-B5C0-393C89295A2AQ28194190-F98A2CF9-B36C-4AF7-8DE7-59F912C47AFFQ28196323-82FF0ED3-29CE-41B9-A2AD-163679BFBA8EQ28210320-C806D555-23B1-4AC0-9D4D-900757DAD6BDQ28211974-36634CE4-79B4-4AC1-B657-27BD15005D8BQ33705493-CEED7772-1562-41BD-A129-2079E3E52335Q33705534-5CD20265-3441-4D23-BF03-FD5885564738Q33836766-C1D2EF46-EE40-43E2-8CBF-287106F13BE1Q34185637-B381D59E-A6FE-4D6B-A3A1-F5A20E736D55Q34295593-6065AD6D-EBB7-4072-8466-9D97236F91E3Q35532086-21F72D2B-7F34-4809-8D29-B334C0535439Q35563238-C00AEFD0-C1E6-406F-A2A2-95FF86E2964FQ35627765-FE9D6CC8-EF2D-48DA-8DB0-1460B9F595C7Q35675869-87BD0EFC-4D22-4D67-82E0-CC53EB7D9362Q35874712-22C04066-1244-4CC5-9BC4-5E4BB286C736Q36289809-ED0BC484-8BEB-4392-94DB-AB3E85066314Q36505616-6E50FC60-8333-4412-A99B-25BCFA24AC5DQ36573399-7BC98C62-81DE-46FB-9409-9E18F7EBA3AEQ36755544-7ABBE7B6-78C2-4D87-8A11-5294EE100C52Q37059125-5BAAF96F-63C7-4009-9052-7E883BF1FA34Q37187622-B4BB75F4-6C99-4B9D-9283-A8E11D3C0BD9Q37698212-44FC7F0B-AF6B-4A20-85F6-8874B440A0BEQ37729070-3BAEFBC7-ACF8-4446-8DAC-771EC0BD9E5FQ37986694-299ACA04-66CC-428A-90E5-DDDA00BB528DQ38062847-A20758CD-B4B3-408A-A904-06C90EB58AD4Q38103710-8A846C3C-2766-4D9A-B57C-441465970C10Q38200702-66892259-9FA3-4FFA-A49E-CBE025A1D681Q38633155-FA11DAEB-CEBB-4CBB-9A88-54B0EDE3C614Q39195090-2B713EEA-FF53-4F25-BE29-DFF3F93DBC32Q40429572-DC89F924-BD0A-4EC4-9508-CE5AA2E0FC05Q40629569-ECCC9601-4C4B-455D-8DAA-97FA239D40B0Q40933985-721BF5C1-06BB-4FF1-AE86-48C96DA4C443Q41082386-CE5D25F5-76BD-4914-BDE8-D715B417C9D2
P2860
Release of leukotrienes, prostaglandins, and histamine into nasal secretions of aspirin-sensitive asthmatics during reaction to aspirin.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@en
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@nl
type
label
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@en
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@nl
prefLabel
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@en
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@nl
P2093
P2860
P356
P1476
Release of leukotrienes, prost ...... cs during reaction to aspirin.
@en
P2093
Ferreri NR
Howland WC
Spiegelberg HL
Stevenson DD
P2860
P304
P356
10.1164/AJRCCM/137.4.847
P577
1988-04-01T00:00:00Z